SINGLE-DOMAIN ANTIBODY AND DERIVATIVES THEREOF TO LIGAND-1 PROTEIN OF PROGRAMMED CELL DEATH (PDLI)

• 收藏
• 分享

专利权人:

发明人:

申请号：

RU2018107427

公开号：

RU2018107427A3

申请日:

申请国别(地区):

RU

年份:

2019

代理人:

摘要：

The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against programmed death ligand (PDL1). In particular, the present invention discloses a programmed death ligand 1 (PDL1) binding molecular and the use thereof, especially the use for treating and/or preventing or diagnosing PDL1 relevant diseases such as tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/